Metal ion binding affinities of gastrin and CCK in membrane mimetic environments.
The fully active gastrin and CCK analogues [Nle 15]-gastrin-17 and [Nle, Thr]-CCK-9 were analysed for their Ca2+ and Tb3+ affinities in various membrane mimetic conditions. In TFE both gastrin and CCK exhibited high affinities for calcium and terbium. At saturation level identical metal ion/peptide ratios were determined with Ca2+ and Tb3+, i.e. R = 3 for gastrin and R = 1 for CCK, confirming the very similar coordination properties of the two metal ions. The conformational effects of both metal ions were found to be very similar with a disordering effect in the case of gastrin and a conformational transition to beta-turn type structure in the case of CCK. In order to mimic more properly physiological conditions, similar experiments were performed in the presence of phospholipid bilayers. No interaction of the peptides with the bilayers was observed even in the presence of mmolar Ca2+ concentrations. Induced lipid interaction via N-terminal lipo-derivatization of gastrin and CCK allowed to translocate quantitatively the two hormones into phospholipid bilayers and to examine the effect of extravesicular Ca2+ on the conformation of the peptide headgroups and on their display at the water/lipid interphase. The CCK moiety of the lipo-CCK inserted into phospholipid bilayers interacts with the lipid phase and addition of Ca2+ enhances the clustering of the peptide headgroups in a more beta-sheet type conformation. Conversely, insertion of lipo-gastrin into the bilayers leads to full exposure of the gastrin headgroup to the bulk water in predominantly random coil structure. Again Ca2+ provokes aggregation. As the lipo-peptide/phospholipid system still represents only an artificial model, it remains hazardous to derive a biological relevance from these data. The significantly higher affinity of lanthanide ions than Ca2+ for the peptides could well play a role in the inhibitory activity of lanthanum on the signal transduction of the CCK family of hormones.
Lutz
J
J
Max-Planck-Institut für Biochemie, Martinsried, Germany.
Weyher
E
E
Moroder
L
L
D000595:Amino Acid Sequence; D002118:Calcium / Q000378:metabolism; D002766:Cholecystokinin / Q000031:analogs & derivatives / Q000737:chemistry / Q000378:metabolism*; D005755:Gastrins / Q000737:chemistry / Q000378:metabolism*; D066298:In Vitro Techniques; D007700:Kinetics; D008081:Liposomes; D008969:Molecular Sequence Data; D015394:Molecular Structure; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism*; D011485:Protein Binding; D017433:Protein Structure, Secondary; D012996:Solutions; D013725:Terbium / Q000378:metabolism; D014270:Trifluoroethanol; D014867:Water
D005755:Gastrins; D008081:Liposomes; D010446:Peptide Fragments; D012996:Solutions; D014867:Water; D013725:Terbium; C079714:DM-gastrin; C083296:dimyristoylmercaptoglycero-N(alpha)maleoyl-beta-alanyl(Thr,Nle)-CCK-9; D014270:Trifluoroethanol; C042874:cholecystokinin (25-33), Thr(28)-Nle(31)-; C037857:gastrin heptadecapeptide, Nle(15)-; D002766:Cholecystokinin; D002118:Calcium